ATE109978T1 - Verwendung von purpuromycin zur behandlung von vaginalinfektionen. - Google Patents

Verwendung von purpuromycin zur behandlung von vaginalinfektionen.

Info

Publication number: ATE109978T1
Authority: AT; Austria
Prior art keywords: purpuromycin; vaginal infections; vaginalis; treat vaginal; antibiotic
Prior art date: 1989-03-31

Application number

AT90105203T

Other languages

English (en)

Inventor

Francesco Parenti

Beth P Goldstein

Luigi Simioni

Original Assignee

Lepetit Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-31

Filing date

1990-03-20

Publication date

1994-09-15

1990-03-20 Application filed by Lepetit Spa filed Critical Lepetit Spa

1994-09-15 Application granted granted Critical

1994-09-15 Publication of ATE109978T1 publication Critical patent/ATE109978T1/de

Links

OZUGVJIHUINCMG-UHFFFAOYSA-N Purpuromycin Natural products COC(=O)C1=Cc2cc3C(O)CC4(Cc5c(O)c6C(=O)C=CC(=O)c6c(O)c5O4)Oc3c(O)c2C(=O)O1 OZUGVJIHUINCMG-UHFFFAOYSA-N 0.000 title abstract 3
208000015181 infectious disease Diseases 0.000 title abstract 3
VGXVKHPGBHVPMW-UHFFFAOYSA-N methyl 4,4',9',10-tetrahydroxy-7'-methoxy-5',8',9-trioxospiro[3,4-dihydropyrano[4,3-g]chromene-2,2'-3h-benzo[f][1]benzofuran]-7-carboxylate Chemical compound OC1=C2C(=O)C(OC)=CC(=O)C2=C(O)C(C2)=C1OC12CC(O)C(C=C2C=C(OC(=O)C2=C2O)C(=O)OC)=C2O1 VGXVKHPGBHVPMW-UHFFFAOYSA-N 0.000 title abstract 3
206010046914 Vaginal infection Diseases 0.000 abstract 2
201000008100 Vaginitis Diseases 0.000 abstract 2
230000003115 biocidal effect Effects 0.000 abstract 2
230000002458 infectious effect Effects 0.000 abstract 2
241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
241000207201 Gardnerella vaginalis Species 0.000 abstract 1
241000224527 Trichomonas vaginalis Species 0.000 abstract 1
231100000676 disease causative agent Toxicity 0.000 abstract 1
239000006208 topical dosage form Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT90105203T 1989-03-31 1990-03-20 Verwendung von purpuromycin zur behandlung von vaginalinfektionen. ATE109978T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP89105686		1989-03-31
EP89109272		1989-05-23

Publications (1)

Publication Number	Publication Date
ATE109978T1 true ATE109978T1 (de)	1994-09-15

Family

ID=26120030

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90105203T ATE109978T1 (de)	1989-03-31	1990-03-20	Verwendung von purpuromycin zur behandlung von vaginalinfektionen.

Country Status (10)

Country	Link
US (1)	US5141953A (de)
EP (1)	EP0389924B1 (de)
JP (1)	JPH02289514A (de)
KR (1)	KR900013971A (de)
AT (1)	ATE109978T1 (de)
AU (1)	AU628946B2 (de)
CA (1)	CA2013277A1 (de)
DE (1)	DE69011557T2 (de)
HU (1)	HU207655B (de)
IL (1)	IL93866A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0447813A1 (de) *	1990-02-28	1991-09-25	GRUPPO LEPETIT S.p.A.	Wasserlösliche Salze von Purpuromycin und dieses enthaltende pharmazeutische Zusammensetzungen
IT1253711B (it) *	1991-12-17	1995-08-23	Alfa Wassermann Spa	Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US7439271B2 (en) *	2001-06-27	2008-10-21	The Gillette Company	Reduction of hair growth
JP4328626B2 (ja) *	2002-01-04	2009-09-09	ノキアコーポレイション	高レート送信ダイバーシティ送信及び受信
WO2005047475A2 (en) *	2003-11-11	2005-05-26	Regents Of The University Of Minnesota	Regulation of cell membrane-mediated effects
US8796332B2 (en)	2004-08-03	2014-08-05	Regents Of The University Of Minnesota	Compositions and methods for controlling infections
US20190224168A1 (en)	2016-07-08	2019-07-25	Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.	Pharmaceutical composition comprising benzydamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1455128A (en) *	1973-03-19	1976-11-10	Lepetit Spa	Purpuromycin and its derivatives

1990
- 1990-03-20 AT AT90105203T patent/ATE109978T1/de active
- 1990-03-20 DE DE69011557T patent/DE69011557T2/de not_active Expired - Fee Related
- 1990-03-20 EP EP90105203A patent/EP0389924B1/de not_active Expired - Lifetime
- 1990-03-21 AU AU52063/90A patent/AU628946B2/en not_active Ceased
- 1990-03-22 US US07/497,378 patent/US5141953A/en not_active Expired - Fee Related
- 1990-03-23 IL IL93866A patent/IL93866A0/xx unknown
- 1990-03-29 JP JP2079082A patent/JPH02289514A/ja active Pending
- 1990-03-29 HU HU901897A patent/HU207655B/hu not_active IP Right Cessation
- 1990-03-29 CA CA002013277A patent/CA2013277A1/en not_active Abandoned
- 1990-03-30 KR KR1019900004289A patent/KR900013971A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
AU628946B2 (en)	1992-09-24
JPH02289514A (ja)	1990-11-29
EP0389924A3 (de)	1991-08-14
EP0389924B1 (de)	1994-08-17
US5141953A (en)	1992-08-25
KR900013971A (ko)	1990-10-22
EP0389924A2 (de)	1990-10-03
DE69011557T2 (de)	1995-03-23
HU207655B (en)	1993-05-28
HUT54299A (en)	1991-02-28
IL93866A0 (en)	1990-12-23
DE69011557D1 (de)	1994-09-22
CA2013277A1 (en)	1990-09-30
AU5206390A (en)	1990-10-04
HU901897D0 (en)	1990-07-28

Similar Documents

Publication	Publication Date	Title
DE3881299D1 (de)	1993-07-01	Retinoide zur behandlung lichtgeschaedigter haut.
BR9306040A (pt)	1997-11-18	Tratamento e profilaxia de doenças provocadas por parasitos ou bactérias
RU94041950A (ru)	1996-09-20	Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
ES2056963T3 (es)	1994-10-16	Agentes antibacterianos.
RU94031102A (ru)	1996-07-10	Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
PT87039A (pt)	1988-04-01	Treatment of human viral infections by dsrna combined with viral inhibitors
DE69221501D1 (de)	1997-09-11	Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
EA200400482A1 (ru)	2004-12-30	Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
NO900251L (no)	1990-07-20	Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.
ATE81776T1 (de)	1992-11-15	Verwendung von chinolon und naphthyridinantibiotika zur herstellung von ophthalmischen arzneimitteln.
DE69130497D1 (de)	1998-12-24	Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE109978T1 (de)	1994-09-15	Verwendung von purpuromycin zur behandlung von vaginalinfektionen.
OA09917A (en)	1994-09-15	Compounds for use in treating HIV infection
BG100599A (en)	1997-02-28	Antiviral form and therapeutical method
DE69004451D1 (de)	1993-12-16	Prophylaxe und Behandlung von Herpesvirus-Infektionen.
RU94021356A (ru)	1996-08-10	Способ лечения протозойных инфекций бацитрацином, применение соли бацитрацина для производства лекарственного препарата
FR2694694B1 (fr)	1994-10-28	Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
RU93003584A (ru)	1995-02-10	Способ лечения синдрома поликистозных яичников
DK120892D0 (da)	1992-09-30	Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
MX9304878A (es)	1994-05-31	Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
DE69210737D1 (de)	1996-06-20	Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
AU3612689A (en)	1989-12-14	Veterinary composition containing ampicillin and cloxacillin for treating eye infection
RU92004825A (ru)	1997-02-27	Мазь для лечения гнойных ран
DE59305285D1 (de)	1997-03-06	Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
PT89582B (pt)	1994-01-31	Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos